Funding Space Exploration: Benefits Beyond Space

Shaelyn Silverman shares her ethics & society case study, which she completed as part of our Young Scientist Program. On July 20, 1969, a surge of national pride rippled through the entire nation when Neil Armstrong uttered what has become one of the most famous and beloved phrases in the history of the United States: “That’s one small step for a man, one giant leap for mankind” [1]. Armstrong had just become the first human to set foot on our moon […]

Read more

Prioritization in Funding Among Competing Projects

Selen Çetin shares her ethics & society case study, which she completed as part of our Young Scientist Program. Given a fixed amount of funding and a series of problems to solve that are related to our future life as human beings; such as the need to explore space, millions of cancer patients awaiting to get cured, or billions of people that cannot afford getting a proper education, suffering from poverty. Which one of them should be of top priority? […]

Read more

Shop at Amazon and Support Us!

You can now directly support Blue Marble Space simply by shopping at Amazon.com! Thanks to the Amazon Smile program, customers can designate a favorite charity to receive 0.5% of all qualifying sales. Please consider supporting us through your regular purchases at Amazon.com, either through this direct link or by navigating to smile.amazon.com and entering “Blue Marble Space” in the search bar. Thanks, as always, for your continued support! [shop now at smile.amazon.com]

Read more

#NoPricks Campaign by Prometheon Pharma

Prometheon Pharma is a startup biotechnology company founded by BMSIS research scientist Dr. Steve Hsu (MD/PhD), and the company launched its international Indiegogo #NoPricks campaign (July 28-Sept 8) to eliminate painful needle injections for insulin, growth hormone, other injectable drugs, as well as vaccines. Prometheon is developing simple, convenient, 7-day, and biodegradable needle-free drug patches that do not need refrigeration. The company is raising funds to support costly studies that will allow it to obtain approval to begin human clinical […]

Read more

Podcast: Are science appropriations appropriate?

Our “Beer with BMSIS” podcast for April features a conversation with our own Dr. Jeff Bowman titled “Dispatch from the AAAS-CAS workshop: How a bill becomes a law, what you can do about it, and are science appropriations appropriate?“. Science today is characterized by uncertain funding cycles that largely are dependent on government support, and many scientists–including professors at large state universities–will receive only partial salary at one (or many) points in their career due to a lack of available […]

Read more
1 2